Clinical Trial Update: Two and Three Dimensional Contrast-enhanced Ultrasound for Screening of Renal Cell Carcinoma Recurrence Following Cryoablation [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating two- and three-dimensional contrast-enhanced ultrasound for screening renal cell carcinoma recurrence after cryoablation; results were …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Snippet

Sponsor: Thomas Jefferson University | Conditions: Renal Cell Carcinoma | Phase 2 | Status: COMPLETED | Results posted: 2019-04-30